0. Advocacy Graphic


  • May 16, 2018

    FDA Approves First Non-Opioid Drug for the Management of Opioid Withdrawal

    On May 16, the Food and Drug Administration (FDA) announced its approval Lucemyra, the first non-opioid treatment for management of opioid withdrawal symptoms. Lucemyra (lofexidine hydrochloride) reduces the release of norepinephrine and can be used to lessen the severity of withdrawal symptoms that may occur after the discontinuation of opioid use.
  • May 14, 2018

    ASAM Applauds DOJ Settlement Enforcing ADA

    On May 14, the Department of Justice’s (DOJ) issued a settlement agreement which found that Charlwell House,  a skilled nursing facility, violated the Americans with Disabilities Act (ADA) by refusing to accept a patient for treatment because the patient was being treated with Suboxone for opioid use disorder (OUD).
  • May 9, 2018

    In Letter to House E&C Committee, American Society of Addiction Medicine Outlines Promising Legislation to Combat America’s Opioid Overdose Epidemic

    Today the American Society of Addiction Medicine (ASAM) submitted a letter to the House Committee on Energy and Commerce as it considers legislation to address the opioid misuse, addiction, and overdose epidemic. The letter, submitted to Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone (D-NJ), urges the Committee to approve bills that expand the provision of evidence-based treatment, strengthen America’s addiction treatment infrastructure, and bolster the nation’s addiction treatment workforce.
  • May 4, 2018

    The American College of Medical Toxicology Joins the Fight to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose (CSOO) is pleased to welcome the American College of Medical Toxicology (ACMT) as a new member of the coalition. ACMT is a professional association of physicians who are Board Certified in Medical Toxicology. Since its inception in 1993, ACMT has worked to advance the practice of medical toxicology and advocates for the care of toxicologic patients and individuals with substance use disorders.
  • April 23, 2018

    Department of HHS Releases Action Plan for Enhanced Enforcement of MH/SUD Coverage

    Today, the Department of Health and Human Services (HHS) issued their Mental Health and Substance Use Disorder Parity Action Plan. Congress included a provision in Section 13002 of the 21st Century Cutes Act requiring HHS to create this Action Plan detailing recent and planned actions from the Departments of HHS, Labor, and Treasury related to ongoing implementation of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA).
  • April 20, 2018

    ASAM Comments on Senate HELP’s Opioid Crisis Response Act Underscore Need For Evidence-Based Practices in Prevention, Treatment and Recovery

    In comments to the Senate Health, Education, Labor and Pensions (HELP) Committee’s Opioid Crisis Response Act of 2018, the American Society of Addiction Medicine (ASAM) today praised committee leadership for addressing the nation’s opioid addiction epidemic and offered legislative recommendations that would increase access to and improve the overall quality of addiction treatment.
  • April 19, 2018

    ASAM Applauds Introduction of New Legislation to Strengthen the Addiction Treatment Workforce

    ASAM applauds Senator Maggie Hassan (D-NH) and Rob Portman (R-OH) for introducing the Enhancing Access to Addiction Treatment Act of 2018. This legislation would establish a new pathway to obtain a DATA waiver and train more new physicians to prescribe medication-assisted treatment.
  • April 16, 2018

    ASAM and the AMA Announce Innovative Payment Model to Improve Treatment of Opioid Use Disorder

    The American Society of Addiction Medicine (ASAM) and the American Medical Association (AMA) jointly announced today the release of a concept paper detailing a groundbreaking alternative payment model (APM) that could revolutionize how patients with opioid use disorder are treated.